logo True scholar network
Back to Top
Visit Website

Future Medicinal Chemistry (FMC)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • ADME/Tox investigations
  • Drug discovery technologies
  • Design and synthesis of novel lead compounds

    • +3

e-ISSN :

1756-8927

Issue Frequency :

Semi-monthly

Impact Factor :

3.2

p-ISSN :

1756-8919

Est. Year :

2009

Mobile :

4402080520500

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

GOOGLE SCHOLAR

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

Medicinal chemistry has evolved rapidly into a highly interdisciplinary field, enriched by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians and physical chemists to molecular biologists and pharmacologists. Future Medicinal Chemistry provides a regular point of access to commentary and debate for this ever-expanding and diversifying community. The journal showcases milestones in pharmaceutical R&D and features expert analysis of emerging research-from the identification of targets, through to the discovery, design, synthesis and evaluation of bioactive agents. There has never been more pressure to produce potent and safe compounds faster and more efficiently. Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.


Future Medicinal Chemistry (FMC) is :

International, Peer-Reviewed, Open Access, Refereed, ADME/Tox investigations, Drug discovery technologies, Design and synthesis of novel lead compounds, Biophysical techniques, Computational approaches, emerging targets , Online or Print, Semi-monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 1756-8919, E-ISSN - 1756-8927, Established in - 2009, Impact Factor - 3.2

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
Crossref

+1 More

Publications of FMC

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile